Review





Similar Products

99
ATCC vitro cytotoxic assay hepg2 human liver hepatocellular carcinoma
Vitro Cytotoxic Assay Hepg2 Human Liver Hepatocellular Carcinoma, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+liver+carcinoma+%28hepg2/pm41900072-383-1-17?v=ATCC
Average 99 stars, based on 1 article reviews
vitro cytotoxic assay hepg2 human liver hepatocellular carcinoma - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

86
Korean Cell Line Bank hepg2 human liver hepatocellular carcinoma cells
Hepg2 Human Liver Hepatocellular Carcinoma Cells, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+liver+carcinoma+%28hepg2/pm42072103-86-0-10?v=Korean+Cell+Line+Bank
Average 86 stars, based on 1 article reviews
hepg2 human liver hepatocellular carcinoma cells - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

99
ATCC hepg2 human liver hepatocellular carcinoma
In vitro cytotoxic activity <t>(HepG2</t> and HT29 cancer cell lines) of isolated compounds (IC 50 in μg/mL). Active compound: 5–15 µg/mL, moderately active compound: 15–50 µg/mL, inactive compound (IC 50 ≥ 50 μg/mL) [ , ].
Hepg2 Human Liver Hepatocellular Carcinoma, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+liver+carcinoma+%28hepg2/pmc13029444-504-0-13?v=ATCC
Average 99 stars, based on 1 article reviews
hepg2 human liver hepatocellular carcinoma - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

99
ATCC human liver carcinoma hepg2
In vitro cytotoxic activity <t>(HepG2</t> and HT29 cancer cell lines) of isolated compounds (IC 50 in μg/mL). Active compound: 5–15 µg/mL, moderately active compound: 15–50 µg/mL, inactive compound (IC 50 ≥ 50 μg/mL) [ , ].
Human Liver Carcinoma Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+liver+carcinoma+%28hepg2/pm41801838-27-8-22?v=ATCC
Average 99 stars, based on 1 article reviews
human liver carcinoma hepg2 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

99
ATCC human liver hepatocellular carcinoma cell line hepg2
In vitro cytotoxic activity <t>(HepG2</t> and HT29 cancer cell lines) of isolated compounds (IC 50 in μg/mL). Active compound: 5–15 µg/mL, moderately active compound: 15–50 µg/mL, inactive compound (IC 50 ≥ 50 μg/mL) [ , ].
Human Liver Hepatocellular Carcinoma Cell Line Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+liver+carcinoma+%28hepg2/10__1002_slash_crat__70085-62-11-18?v=ATCC
Average 99 stars, based on 1 article reviews
human liver hepatocellular carcinoma cell line hepg2 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

99
ATCC human liver carcinoma hepg2 cells
Genotoxic effect observed on LoVo (left) and <t>HepG2</t> (right) cell lines after 24 h incubation with tested preparations containing fulvic acid (MLG-50, MLG-A50) in the range of 1:8192–1:32768. Nucleus damage presented as tail DNA [%] (Lucia Comet Assay™, Laboratory Imaging). PBS was used as a non-treated control (NTC), and 50 µg/mL H 2 O 2 as a treated control. For each independent experiment, 50–100 nucleoids were randomly analyzed per condition. Data are shown as mean ± standard error of the mean (SEM) from four independent experiments ( n = 4). Statistics were performed using one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparisons test; * indicates statistical significance versus the non-treated control (NTC) ( p < 0.05). Criteria for interpretation of damage levels were as follows: ≤5%—no or minor damage; 5–20%—low damage; 20–40%—moderate damage; 40–75%—high damage; >75%—severe damage.
Human Liver Carcinoma Hepg2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+liver+carcinoma+%28hepg2/pmc12905387-41-38-44?v=ATCC
Average 99 stars, based on 1 article reviews
human liver carcinoma hepg2 cells - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

99
ATCC hepg2 human liver carcinoma cells
Cell viability of <t>HepG2</t> cells after treatment with graphene oxide, antisense miRNA-21 and GO–antisense miRNA-21 nanosystems. ( A ) Viability (%) after 24 h exposure to increasing concentrations of GO (5–50 µg/mL), measured by MTT assay, untreated cells were used as control. ( B ) Analysis of cell viability after 24 h following treatment with GO (10 µg/mL), antisense miRNA-21 (5 pmol/mL), and GO–antisense miRNA-21 (10 µg/mL GO + 5 pmol/mL antisense). Data are expressed as percentage relative to untreated control cells. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. Asterisks indicate statistical significance: **** p < 0.0001. Horizontal lines above bars indicate the groups being compared. Abbreviation: Electroporation CTR: electroporation control.
Hepg2 Human Liver Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+liver+carcinoma+%28hepg2/pmc12841687-264-0-5?v=ATCC
Average 99 stars, based on 1 article reviews
hepg2 human liver carcinoma cells - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

99
ATCC human liver hepatocellular carcinoma hepg2 cells
Pb Lig1 is essential for parasite development in the liver. ( A ) <t>HepG2</t> cells were infected with either UIS4/Flp or Pb Lig1 cKO sporozoites. Infected cultures were fixed at the indicated time points post-infection and immunostained with an anti-UIS4 antibody to visualize EEFs. ( B ) EEF area was comparable at 24 hpi ( P = 0.2500) and 36 hpi ( P = 0.1840), but was significantly reduced in Pb Lig1 cKO parasites at 55 hpi (**** P < 0.0001). Data represent the mean ± SEM from three independent experiments. ( C ) Quantification of EEF numbers at 24, 36, and 55 hpi revealed no significant differences between UIS4/Flp and Pb Lig1 cKO parasites (24 hpi, P = 0.6063; 36 hpi, P = 0.9036; 55 hpi, P = 0.9929; one-way ANOVA).
Human Liver Hepatocellular Carcinoma Hepg2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+liver+carcinoma+%28hepg2/pmc12838351-181-0-6?v=ATCC
Average 99 stars, based on 1 article reviews
human liver hepatocellular carcinoma hepg2 cells - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

Image Search Results


In vitro cytotoxic activity (HepG2 and HT29 cancer cell lines) of isolated compounds (IC 50 in μg/mL). Active compound: 5–15 µg/mL, moderately active compound: 15–50 µg/mL, inactive compound (IC 50 ≥ 50 μg/mL) [ , ].

Journal: Molecules

Article Title: Metabolomics, Molecular Networking and Phytochemical Investigation of Psiadia dentata (Cass.) DC., Endemic to Reunion Island: Discovery of Novel Bioactive Molecules

doi: 10.3390/molecules31060973

Figure Lengend Snippet: In vitro cytotoxic activity (HepG2 and HT29 cancer cell lines) of isolated compounds (IC 50 in μg/mL). Active compound: 5–15 µg/mL, moderately active compound: 15–50 µg/mL, inactive compound (IC 50 ≥ 50 μg/mL) [ , ].

Article Snippet: HepG2 human liver hepatocellular carcinoma and HT29 human colorectal adenocarcinoma cells, provided by ATCC HTB-38 were used to assess the toxicity of crude extracts, fractions and pure compounds.

Techniques: In Vitro, Activity Assay, Isolation

Genotoxic effect observed on LoVo (left) and HepG2 (right) cell lines after 24 h incubation with tested preparations containing fulvic acid (MLG-50, MLG-A50) in the range of 1:8192–1:32768. Nucleus damage presented as tail DNA [%] (Lucia Comet Assay™, Laboratory Imaging). PBS was used as a non-treated control (NTC), and 50 µg/mL H 2 O 2 as a treated control. For each independent experiment, 50–100 nucleoids were randomly analyzed per condition. Data are shown as mean ± standard error of the mean (SEM) from four independent experiments ( n = 4). Statistics were performed using one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparisons test; * indicates statistical significance versus the non-treated control (NTC) ( p < 0.05). Criteria for interpretation of damage levels were as follows: ≤5%—no or minor damage; 5–20%—low damage; 20–40%—moderate damage; 40–75%—high damage; >75%—severe damage.

Journal: Scientific Reports

Article Title: Integrated safety and microbiota profiling of fulvic acid formulations across in vitro and in vivo models

doi: 10.1038/s41598-026-37331-2

Figure Lengend Snippet: Genotoxic effect observed on LoVo (left) and HepG2 (right) cell lines after 24 h incubation with tested preparations containing fulvic acid (MLG-50, MLG-A50) in the range of 1:8192–1:32768. Nucleus damage presented as tail DNA [%] (Lucia Comet Assay™, Laboratory Imaging). PBS was used as a non-treated control (NTC), and 50 µg/mL H 2 O 2 as a treated control. For each independent experiment, 50–100 nucleoids were randomly analyzed per condition. Data are shown as mean ± standard error of the mean (SEM) from four independent experiments ( n = 4). Statistics were performed using one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparisons test; * indicates statistical significance versus the non-treated control (NTC) ( p < 0.05). Criteria for interpretation of damage levels were as follows: ≤5%—no or minor damage; 5–20%—low damage; 20–40%—moderate damage; 40–75%—high damage; >75%—severe damage.

Article Snippet: The L929 mouse skin fibroblasts (CCL-1, ATCC, USA) and THP1-BlueTM NF-κB reporter cells (InvivoGen, USA) were cultured in RPMI-1640 medium (Gibco, USA), human colorectal adenocarcinoma LoVo cells (CCL-229, ATCC, USA) were cultured in DMEM/F12 medium (Gibco, USA), and human liver carcinoma HepG2 cells (HB-8065, ATCC, USA) were maintained in DMEM (Gibco, USA).

Techniques: Incubation, Lucia Comet Assay, Imaging, Control

Cell viability of HepG2 cells after treatment with graphene oxide, antisense miRNA-21 and GO–antisense miRNA-21 nanosystems. ( A ) Viability (%) after 24 h exposure to increasing concentrations of GO (5–50 µg/mL), measured by MTT assay, untreated cells were used as control. ( B ) Analysis of cell viability after 24 h following treatment with GO (10 µg/mL), antisense miRNA-21 (5 pmol/mL), and GO–antisense miRNA-21 (10 µg/mL GO + 5 pmol/mL antisense). Data are expressed as percentage relative to untreated control cells. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. Asterisks indicate statistical significance: **** p < 0.0001. Horizontal lines above bars indicate the groups being compared. Abbreviation: Electroporation CTR: electroporation control.

Journal: International Journal of Molecular Sciences

Article Title: Graphene-Based Nanosystem for Targeted Delivery of Anti-Sense miRNA-21 on Hepatocellular Carcinoma Cells

doi: 10.3390/ijms27020975

Figure Lengend Snippet: Cell viability of HepG2 cells after treatment with graphene oxide, antisense miRNA-21 and GO–antisense miRNA-21 nanosystems. ( A ) Viability (%) after 24 h exposure to increasing concentrations of GO (5–50 µg/mL), measured by MTT assay, untreated cells were used as control. ( B ) Analysis of cell viability after 24 h following treatment with GO (10 µg/mL), antisense miRNA-21 (5 pmol/mL), and GO–antisense miRNA-21 (10 µg/mL GO + 5 pmol/mL antisense). Data are expressed as percentage relative to untreated control cells. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. Asterisks indicate statistical significance: **** p < 0.0001. Horizontal lines above bars indicate the groups being compared. Abbreviation: Electroporation CTR: electroporation control.

Article Snippet: HepG2 human liver carcinoma cells (ATCC ® HB-8065TM) were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin.

Techniques: MTT Assay, Control, Electroporation

Evaluation of cellular uptake efficiency of GO, antisense miRNA-21, and GO–antisense miRNA-21 nanosystems in HepG2 cells. ( A ) Flow cytometry analysis of HepG2 cells treated with FITC-labeled GO, antisense miRNA-21, and GO–antisense miRNA-21 for 24 h. The x-axis represents FITC fluorescence intensity, corresponding to the intracellular uptake level of the labeled constructs. Fluorescence intensity was measured to determine the proportion of FITC-positive cells. ( B ) Confocal microscopy imaging of FITC-labeled (green color) constructs in HepG2 cells after 24 h incubation. Cells were counterstained with DAPI (nuclei- blue color) and ActinRed (cytoskeleton-red color). Scale bar: 50 µm. ( C ) Quantitative analysis by flow cytometry showing the percentage of FITC-positive cells after treatment with GO, antisense miRNA-21, and the GO-antisense complex. Data are presented as mean ± SEM.

Journal: International Journal of Molecular Sciences

Article Title: Graphene-Based Nanosystem for Targeted Delivery of Anti-Sense miRNA-21 on Hepatocellular Carcinoma Cells

doi: 10.3390/ijms27020975

Figure Lengend Snippet: Evaluation of cellular uptake efficiency of GO, antisense miRNA-21, and GO–antisense miRNA-21 nanosystems in HepG2 cells. ( A ) Flow cytometry analysis of HepG2 cells treated with FITC-labeled GO, antisense miRNA-21, and GO–antisense miRNA-21 for 24 h. The x-axis represents FITC fluorescence intensity, corresponding to the intracellular uptake level of the labeled constructs. Fluorescence intensity was measured to determine the proportion of FITC-positive cells. ( B ) Confocal microscopy imaging of FITC-labeled (green color) constructs in HepG2 cells after 24 h incubation. Cells were counterstained with DAPI (nuclei- blue color) and ActinRed (cytoskeleton-red color). Scale bar: 50 µm. ( C ) Quantitative analysis by flow cytometry showing the percentage of FITC-positive cells after treatment with GO, antisense miRNA-21, and the GO-antisense complex. Data are presented as mean ± SEM.

Article Snippet: HepG2 human liver carcinoma cells (ATCC ® HB-8065TM) were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin.

Techniques: Flow Cytometry, Labeling, Fluorescence, Construct, Confocal Microscopy, Imaging, Incubation

Quantitative real-time PCR analysis of miRNA expression and pro-inflammatory and tumor-related gene expression in HepG2 cells. ( A ) Transcriptional levels of miRNA-21 in untreated HepG2 cells and in cells treated with GO (10 µg/mL) and with Antisense miRNA-21 (5 pmol/mL) for 24 h. ( B ) Transcriptional levels of IL-8, MCP-1, ICAM-1, TIMP-2 and NF-κB in HepG2 cells. The cells were untreated and treated with GO (10 µg/mL) and GO-antisense miRNA-21 (GO 10 µg/mL + antisense miRNA-21 5 pmol/mL) for 24 h. After, the cells were collected for total RNA extraction. The transcriptional levels of the considered genes were analyzed by calculating the value of 2 −ΔΔCt . The assay was performed in triplicate ± SD and expressed as a fold change over the housekeeping genes. **** p < 0.0001; *** p < 0.001; ** p < 0.01; * p < 0.05.

Journal: International Journal of Molecular Sciences

Article Title: Graphene-Based Nanosystem for Targeted Delivery of Anti-Sense miRNA-21 on Hepatocellular Carcinoma Cells

doi: 10.3390/ijms27020975

Figure Lengend Snippet: Quantitative real-time PCR analysis of miRNA expression and pro-inflammatory and tumor-related gene expression in HepG2 cells. ( A ) Transcriptional levels of miRNA-21 in untreated HepG2 cells and in cells treated with GO (10 µg/mL) and with Antisense miRNA-21 (5 pmol/mL) for 24 h. ( B ) Transcriptional levels of IL-8, MCP-1, ICAM-1, TIMP-2 and NF-κB in HepG2 cells. The cells were untreated and treated with GO (10 µg/mL) and GO-antisense miRNA-21 (GO 10 µg/mL + antisense miRNA-21 5 pmol/mL) for 24 h. After, the cells were collected for total RNA extraction. The transcriptional levels of the considered genes were analyzed by calculating the value of 2 −ΔΔCt . The assay was performed in triplicate ± SD and expressed as a fold change over the housekeeping genes. **** p < 0.0001; *** p < 0.001; ** p < 0.01; * p < 0.05.

Article Snippet: HepG2 human liver carcinoma cells (ATCC ® HB-8065TM) were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin.

Techniques: Real-time Polymerase Chain Reaction, Expressing, Gene Expression, RNA Extraction

Pb Lig1 is essential for parasite development in the liver. ( A ) HepG2 cells were infected with either UIS4/Flp or Pb Lig1 cKO sporozoites. Infected cultures were fixed at the indicated time points post-infection and immunostained with an anti-UIS4 antibody to visualize EEFs. ( B ) EEF area was comparable at 24 hpi ( P = 0.2500) and 36 hpi ( P = 0.1840), but was significantly reduced in Pb Lig1 cKO parasites at 55 hpi (**** P < 0.0001). Data represent the mean ± SEM from three independent experiments. ( C ) Quantification of EEF numbers at 24, 36, and 55 hpi revealed no significant differences between UIS4/Flp and Pb Lig1 cKO parasites (24 hpi, P = 0.6063; 36 hpi, P = 0.9036; 55 hpi, P = 0.9929; one-way ANOVA).

Journal: mSphere

Article Title: Plasmodium DNA ligase I is essential for parasite blood- and liver-stage development

doi: 10.1128/msphere.00674-25

Figure Lengend Snippet: Pb Lig1 is essential for parasite development in the liver. ( A ) HepG2 cells were infected with either UIS4/Flp or Pb Lig1 cKO sporozoites. Infected cultures were fixed at the indicated time points post-infection and immunostained with an anti-UIS4 antibody to visualize EEFs. ( B ) EEF area was comparable at 24 hpi ( P = 0.2500) and 36 hpi ( P = 0.1840), but was significantly reduced in Pb Lig1 cKO parasites at 55 hpi (**** P < 0.0001). Data represent the mean ± SEM from three independent experiments. ( C ) Quantification of EEF numbers at 24, 36, and 55 hpi revealed no significant differences between UIS4/Flp and Pb Lig1 cKO parasites (24 hpi, P = 0.6063; 36 hpi, P = 0.9036; 55 hpi, P = 0.9929; one-way ANOVA).

Article Snippet: Human liver hepatocellular carcinoma (HepG2) cells (ATCC) were used for in vitro infection of sporozoites.

Techniques: Infection

Pb Lig1 is essential for nuclear division and merozoite development. ( A ) HepG2 cells infected with UIS4/Flp or Pb Lig1 cKO sporozoites were fixed at 62 hpi and immunostained with anti-UIS4 and anti-MSP1 antibodies. UIS4/Flp parasites exhibited robust MSP1 staining, indicative of merozoite formation, whereas Pb Lig1 cKO parasites lacked MSP1 signal, suggesting a block in merozoite development. ( B ) Quantification of nuclear number at 55 hpi. Nuclei were manually counted in ImageJ-analyzed images. Pb Lig1 cKO EEFs displayed a significantly reduced number of nuclei compared to UIS4/Flp (**** P < 0.0001, unpaired t -test). ( C ) Quantification of DNA content using Hoechst 33342 staining at 36 hpi and 55 hpi. UIS4/Flp and Pb Lig1 cKO EEFs were fixed and immunostained with anti-UIS4 and anti-MSP1 antibodies. Nuclear DNA within the PV was quantified by calculating corrected total cell fluorescence (CTCF) from Hoechst signal. Data represent 43 (UIS4/Flp 36 hpi), 47 ( Pb Lig1 cKO 36 hpi), 60 (UIS4/Flp 55 hpi), and 60 ( Pb Lig1 cKO 55 hpi) individual EEFs. No significant difference in CTCF was observed at 36 hpi ( P = 0.0693), while a significant reduction was detected in Pb Lig1 cKO parasites at 55 hpi (**** P < 0.0001, unpaired t -test), n.s., not significant. Data are shown as mean ± SD from two independent biological replicates.

Journal: mSphere

Article Title: Plasmodium DNA ligase I is essential for parasite blood- and liver-stage development

doi: 10.1128/msphere.00674-25

Figure Lengend Snippet: Pb Lig1 is essential for nuclear division and merozoite development. ( A ) HepG2 cells infected with UIS4/Flp or Pb Lig1 cKO sporozoites were fixed at 62 hpi and immunostained with anti-UIS4 and anti-MSP1 antibodies. UIS4/Flp parasites exhibited robust MSP1 staining, indicative of merozoite formation, whereas Pb Lig1 cKO parasites lacked MSP1 signal, suggesting a block in merozoite development. ( B ) Quantification of nuclear number at 55 hpi. Nuclei were manually counted in ImageJ-analyzed images. Pb Lig1 cKO EEFs displayed a significantly reduced number of nuclei compared to UIS4/Flp (**** P < 0.0001, unpaired t -test). ( C ) Quantification of DNA content using Hoechst 33342 staining at 36 hpi and 55 hpi. UIS4/Flp and Pb Lig1 cKO EEFs were fixed and immunostained with anti-UIS4 and anti-MSP1 antibodies. Nuclear DNA within the PV was quantified by calculating corrected total cell fluorescence (CTCF) from Hoechst signal. Data represent 43 (UIS4/Flp 36 hpi), 47 ( Pb Lig1 cKO 36 hpi), 60 (UIS4/Flp 55 hpi), and 60 ( Pb Lig1 cKO 55 hpi) individual EEFs. No significant difference in CTCF was observed at 36 hpi ( P = 0.0693), while a significant reduction was detected in Pb Lig1 cKO parasites at 55 hpi (**** P < 0.0001, unpaired t -test), n.s., not significant. Data are shown as mean ± SD from two independent biological replicates.

Article Snippet: Human liver hepatocellular carcinoma (HepG2) cells (ATCC) were used for in vitro infection of sporozoites.

Techniques: Infection, Staining, Blocking Assay, Fluorescence